For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
Jump to a slide with the slide dots.
Discover how AI-powered speech analytics is revolutionizing customer experience, improving compliance, and enabling smarter decision-making at scale.
Read moreThe decision-making process of community physicians is complex, yet gaining meaningful insights into it remains one of the most challenging aspects
Read moreAlthough individually uncommon, rare health conditions collectively affect more than 300 million people worldwide. To mark Rare Disease Day on 28 Febr
Read more